187 results on '"Clayton, Richard N."'
Search Results
2. Supplementary Tables S1-S2 from Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors
3. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study
4. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study
5. Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality
6. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells
7. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
8. Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies
9. Direct Inhibition of Testicular Function by Gonadotropin-Releasing Hormone: Mediation by Specific Gonadotropin-Releasing Hormone Receptors in Interstitial Cells
10. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
11. A Paradigm Shift in the Monitoring of Patients With Acromegaly: Last Available Growth Hormone May Overestimate Risk
12. Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
13. Corticotroph Carcinoma Presenting as a Silent Corticotroph Adenoma
14. Preincubation of Pituitary Tumor Cells With the Epidrugs Zebularine and Trichostatin A Are Permissive for Retinoic Acid-Augmented Expression of the BMP-4 and D2R Genes
15. The pituitary tumour epigenome: aberrations and prospects for targeted therapy
16. Epigenomic Silencing of the BMP-4 Gene in Pituitary Adenomas: A Potential Target for Epidrug-Induced Re-expression
17. Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis
18. Obesity and Polycystic Ovary Syndrome
19. Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis
20. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
21. Spontaneous pregnancy after trans-sphenoidal surgery in a patient with lymphocytic hypophysitis
22. Carbimazole therapy in the setting of end-stage renal disease and haemodialysis
23. Isolation and Characterization of a Novel Pituitary Tumor Apoptosis Gene
24. Excess Vascular Mortality in Hypopituitarism: Is it the Result of Estrogen or GH Deficiency?
25. Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma
26. Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas
27. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities
28. Endogenous inhibitors of 11β-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome
29. Transfection of an Inducible p16/CDKN2A Construct Mediates Reversible Growth Inhibition and G1 Arrest in the AtT20 Pituitary Tumor Cell Line
30. Low Expression of the Cell Cycle Inhibitor p27Kip1 in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary Tumors
31. Response to Dr. Oelkers: There Is Enough Evidence in Favor of Low Dose ACTH Test-Authors’ Responseb
32. A New Contributing Factor to Polycystic Ovary Syndrome: The Genetic Variant of Luteinizing Hormone*
33. Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults*
34. Molecular biology of human pituitary adenomas
35. Hyperandrogenism In Polycystic Ovary Syndrome
36. Endothelial dysfunction in endocrine disease
37. Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (Zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer
38. [2] Preparation of radiolabeled neuroendocrine peptides
39. Regulation of Peptide Hormone Receptors and Gonadal Steroidogenesis
40. Obesity and PCOS
41. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas
42. Etanercept-Induced Hypoglycemia And Improved Glycemic Control In A Patient With type 2 Diabetes
43. Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis
44. Editorial
45. Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors
46. Primary colorectal tumors fail to express the proapoptotic mediator PTAG and its reexpression augments drug‐induced apoptosis
47. Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease
48. Medroxyprogesterone at High Altitude. The Effects on Blood Gases, Cerebral Regional Oxygenation, and Acute Mountain Sickness☆☆☆
49. Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
50. Molecular Pathogenesis of Pituitary Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.